Literature DB >> 17575281

Primary episodic ataxias: diagnosis, pathogenesis and treatment.

J C Jen1, T D Graves, E J Hess, M G Hanna, R C Griggs, R W Baloh.   

Abstract

Primary episodic ataxias are autosomal dominant channelopathies that manifest as attacks of imbalance and incoordination. Mutations in two genes, KCNA1 and CACNA1A, cause the best characterized and account for the majority of identified cases of episodic ataxia. We summarize current knowledge of clinical and genetic diagnosis, genotype-phenotype correlations, pathophysiology and treatment of episodic ataxia syndromes. We focus on unresolved issues including phenotypic and genetic heterogeneity, lessons from animal models and technological advancement, rationale and feasibility of various treatment strategies, and shared mechanisms underlying episodic ataxia and other far more prevalent paroxysmal conditions such as epilepsy and migraine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17575281     DOI: 10.1093/brain/awm126

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  105 in total

1.  VOLTAGE-GATED CALCIUM CHANNELS ARE NOT AFFECTED BY THE NOVEL ANTI-EPILEPTIC DRUG LACOSAMIDE.

Authors:  Yuying Wang; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2011-03       Impact factor: 1.757

Review 2.  Genetic disorders of ion channels.

Authors:  Decha Enkvetchakul
Journal:  Mo Med       Date:  2010 Jul-Aug

Review 3.  Axon initial segment dysfunction in epilepsy.

Authors:  Verena C Wimmer; Christopher A Reid; Eva Y-W So; Samuel F Berkovic; Steven Petrou
Journal:  J Physiol       Date:  2010-04-07       Impact factor: 5.182

4.  KCa channels as therapeutic targets in episodic ataxia type-2.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

5.  The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

6.  Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.

Authors:  Christophe Marcel; Mathieu Anheim; Constance Flamand-Rouvière; Françoise Heran; Pascal Masnou; Clotilde Boulay; Ivan Mari; Christine Tranchant; Emmanuel Roze
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

7.  A novel de novo pathogenic mutation in the CACNA1A gene.

Authors:  Shinsuke Fujioka; Sruti Rayaprolu; Christina Sundal; Daniel F Broderick; William A Langley; John Shoffner; Lauren C Hyams; Rosa Rademakers; Neill R Graff-Radford; William Tatum; Owen A Ross; Zbigniew K Wszolek
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

8.  Novel CACNA1A mutation(s) associated with slow saccade velocities.

Authors:  Stefan Kipfer; Simon Jung; Johannes R Lemke; Anna Kipfer-Kauer; Jeremy P Howell; Alain Kaelin-Lang; Thomas Nyffeler; Klemens Gutbrod; Angela Abicht; René M Müri
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

9.  Low-frequency oscillations in the cerebellar cortex of the tottering mouse.

Authors:  Gang Chen; Laurentiu S Popa; Xinming Wang; Wangcai Gao; Justin Barnes; Claudia M Hendrix; Ellen J Hess; Timothy J Ebner
Journal:  J Neurophysiol       Date:  2008-11-05       Impact factor: 2.714

10.  Familial dyskinesia and facial myokymia (FDFM): Follow-up of a large family and linkage to chromosome 3p21-3q21.

Authors:  Wendy H Raskind; Mark Matsushita; Beate Peter; Jeffrey Biberston; John Wolff; Hillary Lipe; Ruben Burbank; Thomas D Bird
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.